A Form 4 filed with the SEC on September 16, 2026 discloses that Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (NASDAQ:SOPH), sold 4,000 ordinary shares on September 14, 2026 under a Rule 10b5-1 trading plan.
Key Highlights
- Reporting person: Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA
- Transaction: 4,000 ordinary shares disposed of (transaction code S) on September 14, 2026
- Weighted average price: $7.8844 per share, with individual sales ranging from $7.78 to $7.99, inclusive
- Rule 10b5-1 plan: The transaction was made pursuant to a duly adopted trading plan under Rule 10b5-1(c)
- Remaining ownership: 552,887 ordinary shares beneficially owned directly following the transaction
Xu Zhenyu's Share Sale Details and Remaining Stake in SOPHiA GENETICS
According to the filing, Xu Zhenyu, serving as Chief Scientific Officer of SOPHiA GENETICS SA, disposed of 4,000 ordinary shares on September 14, 2026. The form was signed on September 16, 2026 by Elimara Brunetto as attorney-in-fact for Zhenyu Xu. The transaction is classified under code "S" in Table I of the Form 4, indicating an open-market sale of non-derivative securities.
The filing discloses that the price of $7.8844 reported is a weighted average, as the shares were sold across multiple transactions at prices ranging from $7.78 to $7.99, inclusive. Per the filing, the reporting person "undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
Following the reported transaction, Xu Zhenyu directly holds 552,887 ordinary shares, according to the filing. No derivative securities transactions were reported in Table II. The filing confirms the transaction was executed pursuant to a duly adopted trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), as indicated by the checked box on the form.
What Was Disclosed
The Form 4 filed September 16, 2026 reports that SOPHiA GENETICS SA Chief Scientific Officer Xu Zhenyu sold 4,000 ordinary shares on September 14, 2026 at a weighted average price of $7.8844, under a Rule 10b5-1 plan, retaining direct ownership of 552,887 shares.



Please wait processing your request...